137 related articles for article (PubMed ID: 12424718)
1. The optimal number of donor biopsy sites to evaluate liver histology for transplantation.
Frankel WL; Tranovich JG; Salter L; Bumgardner G; Baker P
Liver Transpl; 2002 Nov; 8(11):1044-50. PubMed ID: 12424718
[TBL] [Abstract][Full Text] [Related]
2. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation.
Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A
Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115
[TBL] [Abstract][Full Text] [Related]
4. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
5. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
de Graaf EL; Kench J; Dilworth P; Shackel NA; Strasser SI; Joseph D; Pleass H; Crawford M; McCaughan GW; Verran DJ
J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
[TBL] [Abstract][Full Text] [Related]
6. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers.
Yersiz H; Lee C; Kaldas FM; Hong JC; Rana A; Schnickel GT; Wertheim JA; Zarrinpar A; Agopian VG; Gornbein J; Naini BV; Lassman CR; Busuttil RW; Petrowsky H
Liver Transpl; 2013 Apr; 19(4):437-49. PubMed ID: 23408461
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of reduced-size orthotopic liver transplantation with fatty grafts and its potential regeneration in rats.
Sheng Y; Jiahong D; Benli H
Arch Med Res; 2009 Apr; 40(3):146-55. PubMed ID: 19427964
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation.
Cho JY; Suh KS; Lee HW; Cho EH; Yang SH; Cho YB; Yi NJ; Kim MA; Jang JJ; Lee KU
Transpl Int; 2006 Oct; 19(10):807-13. PubMed ID: 16961772
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
11. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease.
Merriman RB; Ferrell LD; Patti MG; Weston SR; Pabst MS; Aouizerat BE; Bass NM
Hepatology; 2006 Oct; 44(4):874-80. PubMed ID: 17006934
[TBL] [Abstract][Full Text] [Related]
12. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
13. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C.
Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC
Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440
[TBL] [Abstract][Full Text] [Related]
14. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
[TBL] [Abstract][Full Text] [Related]
15. High-grade microsteatosis and delay in hepatic function after orthotopic liver transplantation.
Sharkey FE; Lytvak I; Prihoda TJ; Speeg KV; Washburn WK; Halff GA
Hum Pathol; 2011 Sep; 42(9):1337-42. PubMed ID: 21420717
[TBL] [Abstract][Full Text] [Related]
16. Preoperative donor liver biopsy for adult living donor liver transplantation: risks and benefits.
Nadalin S; Malagó M; Valentin-Gamazo C; Testa G; Baba HA; Liu C; Frühauf NR; Schaffer R; Gerken G; Frilling A; Broelsch CE
Liver Transpl; 2005 Aug; 11(8):980-6. PubMed ID: 16035060
[TBL] [Abstract][Full Text] [Related]
17. Correlation between hepatic steatosis, hepatic volume, and spleen volume in live liver donors.
Chen TY; Chen CL; Tsang LL; Huang TL; Wang CC; Concejero AM; Lu CH; Cheng YF
Transplant Proc; 2008 Oct; 40(8):2481-3. PubMed ID: 18929772
[TBL] [Abstract][Full Text] [Related]
18. Steatosis in donor and transplant liver biopsies.
Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
[TBL] [Abstract][Full Text] [Related]
19. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
[TBL] [Abstract][Full Text] [Related]
20. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P
J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
